These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 23617712)
21. Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trial. Armour CL; Reddel HK; LeMay KS; Saini B; Smith LD; Bosnic-Anticevich SZ; Song YJ; Alles MC; Burton DL; Emmerton L; Stewart K; Krass I J Asthma; 2013 Apr; 50(3):302-9. PubMed ID: 23270495 [TBL] [Abstract][Full Text] [Related]
22. Exhaled NO is a poor marker of asthma control in children with a reported use of asthma medication: a pharmacy-based study. Vijverberg SJ; Koster ES; Koenderman L; Arets HG; van der Ent CK; Postma DS; Koppelman GH; Raaijmakers JA; Maitland-van der Zee AH Pediatr Allergy Immunol; 2012 Sep; 23(6):529-36. PubMed ID: 22624949 [TBL] [Abstract][Full Text] [Related]
23. Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%. Becker A; Swern A; Tozzi CA; Yu Q; Reiss T; Knorr B Curr Med Res Opin; 2004 Oct; 20(10):1651-9. PubMed ID: 15462699 [TBL] [Abstract][Full Text] [Related]
24. Sleep quality in asthma: results of a large prospective clinical trial. Mastronarde JG; Wise RA; Shade DM; Olopade CO; Scharf SM; J Asthma; 2008 Apr; 45(3):183-9. PubMed ID: 18415823 [TBL] [Abstract][Full Text] [Related]
25. Effectiveness of a comprehensive lifestyle modification program for asthma patients: a randomized controlled pilot trial. Pokladnikova J; Selke-Krulichova I J Asthma; 2013 Apr; 50(3):318-26. PubMed ID: 23379542 [TBL] [Abstract][Full Text] [Related]
26. The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma. Straub DA; Moeller A; Minocchieri S; Hamacher J; Sennhauser FH; Hall GL; Wildhaber JH Eur Respir J; 2005 Feb; 25(2):289-94. PubMed ID: 15684293 [TBL] [Abstract][Full Text] [Related]
28. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial). Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768 [TBL] [Abstract][Full Text] [Related]
30. Educational intervention for older people with asthma: a randomised controlled trial. Goeman D; Jenkins C; Crane M; Paul E; Douglass J Patient Educ Couns; 2013 Dec; 93(3):586-95. PubMed ID: 24007766 [TBL] [Abstract][Full Text] [Related]
31. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening AP; Haahtela T; Holgate ST; Picado C; Menten J; Dass SB; Leff JA; Polos PG BMJ; 2003 Oct; 327(7420):891. PubMed ID: 14563743 [TBL] [Abstract][Full Text] [Related]
32. A randomized, controlled study to evaluate the role of an in-home asthma disease management program provided by respiratory therapists in improving outcomes and reducing the cost of care. Shelledy DC; Legrand TS; Gardner DD; Peters JI J Asthma; 2009 Mar; 46(2):194-201. PubMed ID: 19253130 [TBL] [Abstract][Full Text] [Related]
33. Quality of life in primary care asthma. Ehrs PO; Aberg H; Larsson K Respir Med; 2001 Jan; 95(1):22-30. PubMed ID: 11207013 [TBL] [Abstract][Full Text] [Related]
35. Relationship of the asthma control test with pulmonary function and exhaled nitric oxide. Shirai T; Furuhashi K; Suda T; Chida K Ann Allergy Asthma Immunol; 2008 Dec; 101(6):608-13. PubMed ID: 19119704 [TBL] [Abstract][Full Text] [Related]
36. Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler. Chervinsky P; Baker J; Bensch G; Parasuraman B; Boggs R; Martin P; O'Dowd L Ann Allergy Asthma Immunol; 2008 Nov; 101(5):463-73. PubMed ID: 19055199 [TBL] [Abstract][Full Text] [Related]
37. Benefit from anti-inflammatory treatment during clinical remission of atopic asthma. van den Toorn LM; Prins JB; de Jongste JC; Leman K; Mulder PG; Hoogsteden HC; Overbeek SE Respir Med; 2005 Jun; 99(6):779-87. PubMed ID: 15878496 [TBL] [Abstract][Full Text] [Related]
39. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study. Busse W; Levine B; Andriano K; Lavecchia C; Yegen U Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475 [TBL] [Abstract][Full Text] [Related]
40. Asthma control test is correlated to FEV1 and nitric oxide in Greek asthmatic patients: influence of treatment. Papakosta D; Latsios D; Manika K; Porpodis K; Kontakioti E; Gioulekas D J Asthma; 2011 Nov; 48(9):901-6. PubMed ID: 21923284 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]